Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Advanced Solid Tumors × Nivolumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Hodgkin Disease 2 Recurrent Squamous Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Gastric and Esophagogastric Junction Adenocarcinoma 1 Colorectal Neoplasms 1 Carcinoma 1 Advanced Solid Tumors 1 Adenocarcinoma 1

Interventions

Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03461952 2024-02-22

NIMBLe

Canadian Cancer Trials Group

Phase 2 Terminated

4 enrolled 4 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡